Forecaster

Forecaster

The RXA Forecaster tool produces forecasts of the predicted sales of pharmaceutical companies’ product portfolios, based on historic prescribing trends.

With the RXA Forecaster you can plan for the future, set sales targets and keep track of sales activity at territory and CCG levels.

With the RXA Forecaster tool you can:

  • Employ methodologies, including the Holt-Winters seasonal method
  • Include user-defined parameters – E.g. expected level of product switch, underlying market growth etc.
  • Produce actual vs. forecast comparisons to help assess forecast accuracy
We make analytics simple
Request your demonstration today

“Need to analyse the community market? This tool can do that.”

Senior Manager, Global Healthcare Company, 2016

“Rx Analyser is already having a significant impact on our business, allowing our Territory Managers to focus on established CCG accounts and identify practice level successes and others for further development.”

Managing Director, UK Diabetes Healthcare Company

“Benefits? The range of views of the data allows for easier business planning. The data being as up to date as possible enables swift response to market changes. And the ease of changing hierarchy allows for easy management reporting and oversight.”

National Sales Manager, UK Pharmaceutical Company

“If I had to choose one feature about Rx Analyser it would be the “market overview,” which gives a great snapshot of the market from practice up to National level.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“I use the data from RXA Budget Impact Model daily. It is the core of everything we do! I cannot recommend the model more. It has had a substantial impact on our business across the board and I would not be without it.”

Country Manager UK, Leading Diagnostics Company

“Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.”

Andrew Norman and David Warwick, Directors

Sign up for added insights